Literature DB >> 31360995

Recent Substance Use and Probability of Unsuppressed HIV Viral Load Among Persons on Antiretroviral Therapy in Continuity Care.

Catherine R Lesko1, Alexander P Keil2, Anthony T Fojo3, Geetanjali Chander1,3, Bryan Lau1, Richard D Moore1,3.   

Abstract

Among persons with human immunodeficiency virus (HIV) infection, illegal drug use and hazardous alcohol use are hypothesized to be strong risk factors for failure to achieve or maintain a suppressed HIV viral load, but accurate quantification of this association is difficult because of challenges involved in measuring substance use as part of routine clinical care. We estimated the associations of recent cocaine use, opioid/heroin use, and hazardous alcohol use with unsuppressed viral load among 1,554 persons receiving care at the John G. Bartlett Specialty Practice (Baltimore, Maryland) between 2013 and 2017. We accounted for measurement error in substance use using Bayesian models and prior estimates of the sensitivity and specificity of 2 imperfect measures of substance use derived from a previous analysis in this cohort. The prevalence difference for unsuppressed viral load associated with recent cocaine use was 11.3% (95% credible interval (CrI): 6.4, 17.0); that associated with recent opioid/heroin use was 13.2% (95% CrI: 6.6, 20.7); and that associated with recent hazardous alcohol use was 8.5% (95% CrI: 3.2, 14.4). Failure to account for measurement error resulted in clinically meaningful underestimates of the prevalence difference. Time-varying substance use is prevalent and difficult to measure in routine care; here we demonstrate a method that improves the utility of imperfect data by accounting for measurement error.
© The Author(s) 2019. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Bayesian analysis; HIV; alcohol use; cocaine use; measurement error; opioid use; substance use

Mesh:

Substances:

Year:  2019        PMID: 31360995      PMCID: PMC6768806          DOI: 10.1093/aje/kwz159

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  22 in total

1.  Measurement of Current Substance Use in a Cohort of HIV-Infected Persons in Continuity HIV Care, 2007-2015.

Authors:  Catherine R Lesko; Alexander P Keil; Richard D Moore; Geetanjali Chander; Anthony T Fojo; Bryan Lau
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

2.  Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.

Authors:  R D Moore
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

3.  Impaired virologic response to highly active antiretroviral therapy associated with ongoing injection drug use.

Authors:  Anita Palepu; Mark Tyndall; Benita Yip; Michael V O'Shaughnessy; Robert S Hogg; Julio S G Montaner
Journal:  J Acquir Immune Defic Syndr       Date:  2003-04-15       Impact factor: 3.731

4.  At-Risk Alcohol Use Among HIV-Positive Patients and the Completion of Patient-Reported Outcomes.

Authors:  Jacqueline E Rudolph; Stephen R Cole; Jessie K Edwards; Richard Moore; Conall O'Cleirigh; Wm Christopher Mathews; Katerina Christopoulos
Journal:  AIDS Behav       Date:  2018-04

5.  Estimating the error rates of diagnostic tests.

Authors:  S L Hui; S D Walter
Journal:  Biometrics       Date:  1980-03       Impact factor: 2.571

6.  Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.

Authors:  Gregory M Lucas; Kelly A Gebo; Richard E Chaisson; Richard D Moore
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

7.  HIV Viral Suppression Trends Over Time Among HIV-Infected Patients Receiving Care in the United States, 1997 to 2015: A Cohort Study.

Authors:  Robin M Nance; J A Chris Delaney; Jane M Simoni; Ira B Wilson; Kenneth H Mayer; Bridget M Whitney; Frances M Aunon; Steven A Safren; Michael J Mugavero; W Christopher Mathews; Katerina A Christopoulos; Joseph J Eron; Sonia Napravnik; Richard D Moore; Benigno Rodriguez; Bryan Lau; Rob J Fredericksen; Michael S Saag; Mari M Kitahata; Heidi M Crane
Journal:  Ann Intern Med       Date:  2018-08-21       Impact factor: 25.391

8.  Alcohol consumption and antiretroviral adherence among HIV-infected persons with alcohol problems.

Authors:  Jeffrey H Samet; Nicholas J Horton; Seville Meli; Kenneth A Freedberg; Anita Palepu
Journal:  Alcohol Clin Exp Res       Date:  2004-04       Impact factor: 3.455

9.  AUDIT-C as a brief screen for alcohol misuse in primary care.

Authors:  Katharine A Bradley; Anna F DeBenedetti; Robert J Volk; Emily C Williams; Danielle Frank; Daniel R Kivlahan
Journal:  Alcohol Clin Exp Res       Date:  2007-04-19       Impact factor: 3.455

10.  A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU.

Authors:  Catherine R Lesko; Jessie K Edwards; Richard D Moore; Bryan Lau
Journal:  AIDS       Date:  2016-09-10       Impact factor: 4.177

View more
  6 in total

1.  Treatment for alcohol use disorder among persons with and without HIV in a clinical care setting in the United States.

Authors:  Thibaut Davy-Mendez; Varada Sarovar; Tory Levine-Hall; Alexandra N Lea; Stacy A Sterling; Felicia W Chi; Vanessa A Palzes; Kendall J Bryant; Constance M Weisner; Michael J Silverberg; Derek D Satre
Journal:  Drug Alcohol Depend       Date:  2021-09-28       Impact factor: 4.492

2.  Characterizing Unhealthy Alcohol Use Patterns and Their Association with Alcohol Use Reduction and Alcohol Use Disorder During Follow-Up in HIV Care.

Authors:  Thibaut Davy-Mendez; Varada Sarovar; Tory Levine-Hall; Alexandra N Lea; Stacy A Sterling; Felicia W Chi; Vanessa A Palzes; Mitchell N Luu; Jason A Flamm; C Bradley Hare; Emily C Williams; Kendall J Bryant; Constance M Weisner; Michael J Silverberg; Derek D Satre
Journal:  AIDS Behav       Date:  2022-09-28

3.  Patterns of alcohol use and associated characteristics and HIV-related outcomes among a sample of African-American women living with HIV.

Authors:  Lauren Lipira; Deepa Rao; Paul E Nevin; Christopher G Kemp; Susan E Cohn; Janet M Turan; Jane M Simoni; Michele P Andrasik; Audrey L French; Joseph M Unger; Patrick Heagerty; Emily C Williams
Journal:  Drug Alcohol Depend       Date:  2019-11-20       Impact factor: 4.492

4.  Gender differences among criminal justice-involved persons living with HIV interested in extended-release naltrexone treatment.

Authors:  Breanne E Biondi; Cynthia A Frank; Ariadna Forray; Sandra A Springer
Journal:  Subst Abus       Date:  2021-03-22       Impact factor: 3.716

5.  Changing Patterns of Alcohol Use and Probability of Unsuppressed Viral Load Among Treated Patients with HIV Engaged in Routine Care in the United States.

Authors:  Catherine R Lesko; Robin M Nance; Bryan Lau; Anthony T Fojo; Heidi E Hutton; Joseph A C Delaney; Heidi M Crane; Karen L Cropsey; Kenneth H Mayer; Sonia Napravnik; Elvin Geng; W Christopher Mathews; Mary E McCaul; Geetanjali Chander
Journal:  AIDS Behav       Date:  2020-10-16

6.  Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use.

Authors:  Sharleen M Traynor; Lisa R Metsch; Lauren Gooden; Maxine Stitzer; Tim Matheson; Susan Tross; Adam W Carrico; Mamta K Jain; Carlos Del Rio; Daniel J Feaster
Journal:  Drug Alcohol Depend       Date:  2021-02-03       Impact factor: 4.492

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.